NorthCoast Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
NorthCoast Asset Management's DGX Position: Q3 2021 in Review
NorthCoast Asset Management increased its Quest Diagnostics (DGX) stake by 57% in Q3 2021, buying an estimated $643K and bringing the position to 12,141 shares worth $1.77M. The position accounts for 0.06% of the portfolio, ranked #193.
NorthCoast Asset Management first reported a position in DGX in Q1 2017 and has held it in 15 quarters since. The position peaked at $23.9M in Q1 2018. 838 funds tracked by Wall St. Rank hold DGX as of Q3 2021.
- NorthCoast Asset Management held 12,141 shares of Quest Diagnostics worth $1.77M as of Q3 2021.
- NorthCoast Asset Management bought 4,396 Quest Diagnostics shares in Q3 2021, an estimated $643K.
- Quest Diagnostics made up 0.06% of NorthCoast Asset Management's portfolio in Q3 2021, its #193 holding.
- NorthCoast Asset Management first reported a position in Quest Diagnostics in Q1 2017 and has held it in 15 quarters since.
- NorthCoast Asset Management's Quest Diagnostics position peaked at $23.9M in Q1 2018.
- 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.
Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.